Dragon Pharma PNC-27 10 mg
Dragon Pharma's PNC-27 10 mg is a cutting-edge experimental peptide that represents a significant advancement in targeted cellular research. This 32-amino-acid synthetic peptide has garnered substantial scientific interest for its unique mechanism of action, specifically targeting membrane-bound HDM-2 proteins that are overexpressed on the surface of tumor cells. By binding to these specific proteins, PNC-27 induces a process of cell lysis and necrosis, effectively destroying targeted cells while leaving healthy cells unaffected.
The mechanism of action of PNC-27 is both elegant and highly specific. The peptide is designed to recognize and bind to the HDM-2 protein, which is present in high concentrations on the membranes of various cancer cell types. Once bound, PNC-27 disrupts the integrity of the cell membrane, creating pores that lead to rapid cell lysis and necrosis. This process is distinct from apoptosis (programmed cell death) and represents a different pathway of cellular destruction that may be effective against certain cell types that are resistant to apoptosis.
For bodybuilders and athletes, the relevance of PNC-27 lies primarily in the context of long-term health optimization and risk management. The use of anabolic steroids and growth factors can, in some cases, increase the risk of certain cellular abnormalities and tumor growth. While PNC-27 is not a preventative measure in the traditional sense, its targeted mechanism offers a research-based approach to addressing cellular health at a fundamental level.
The peptide's ability to induce necrosis specifically in cells expressing HDM-2 on their surface is particularly significant because HDM-2 is a known oncogene that is overexpressed in many cancers. By targeting this specific protein, PNC-27 offers a level of specificity that is rarely achieved with conventional treatments. This selectivity is what makes PNC-27 such an exciting area of research for those interested in cellular health and targeted therapeutic approaches.
PNC-27 has been studied in various preclinical models with promising results. Research has demonstrated its effectiveness against multiple cancer cell lines, including breast, lung, colon, and prostate cancer cells. In animal models, PNC-27 has shown the ability to significantly reduce tumor size without the severe side effects commonly associated with traditional chemotherapeutic agents. This is attributed to its highly targeted mechanism of action, which spares healthy tissues from damage.
For individuals concerned about the long-term health implications of their training and supplementation regimens, PNC-27 offers a research-grade tool for exploring cellular health at the molecular level. Its ability to target cells that express specific oncogenic markers makes it a valuable compound for those interested in proactive health management and cellular wellness research.
It is important to emphasize that PNC-27 is an experimental compound intended for research purposes only. The science surrounding this peptide is rapidly evolving, and it represents the cutting edge of targeted peptide therapeutics. Users should approach it with the respect and consideration appropriate for any powerful biological agent, understanding its potential applications while recognizing the need for comprehensive research and proper protocols.
Key Benefits:
- Targeted HDM-2 Binding: Specifically recognizes and binds to membrane-bound HDM-2 proteins overexpressed on tumor cells, ensuring selective targeting.
- Cell Lysis & Necrosis Induction: Creates pores in the cell membrane of targeted cells, leading to rapid lysis and necrosis without damaging healthy cells.
- High Specificity: Designed to spare healthy tissues by targeting only cells that overexpress HDM-2 on their surface, reducing the risk of off-target effects.
- Research-Grade Purity: Manufactured to the highest standards for research applications, ensuring reliability and consistency in experimental settings.
- Innovative Therapeutic Approach: Represents a novel mechanism of action distinct from traditional apoptosis induction, offering unique research applications.
Each package contains one 2 mL glass vial with 10 mg of lyophilized PNC-27 powder, manufactured under strict quality control standards in Dragon Pharma's certified European facilities. The product requires reconstitution with bacteriostatic water prior to use.
Product Specifications
| Product Name |
PNC-27 10 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
PNC-27 (32-Amino-Acid Peptide) |
| Packaging |
2 mL Glass Vial (Lyophilized Powder) |
| Lab Test Result |
HPLC Verified (≥98% Purity) |
| Half-Life |
Approximately 3-4 hours |
| Recommended Cycle |
4-8 Weeks |
| Form |
Lyophilized Powder |
| Aromatization |
No |
| Dosage (Men) |
100-300 mcg per day |
Usage Guidelines
PNC-27 is typically administered via subcutaneous or intramuscular injection after reconstitution with bacteriostatic water. Based on preclinical research and user experience, the following protocols have been explored for research purposes.
- Beginner Protocol: 100 mcg administered once daily for 4 weeks. This dosage is recommended for first-time users to assess tolerance and initial response.
- Intermediate Protocol: 200 mcg daily for 6 weeks. This is the most common protocol for research applications and general cellular health support.
- Advanced Protocol: 300 mcg daily, divided into two doses (morning and evening), for 8 weeks. This protocol is for those seeking maximum research outcomes.
Recommended Stacking Strategies:
PNC-27 can be strategically combined with other Dragon Pharma products for comprehensive cellular health research. For enhanced immune support and overall wellness, stacking with Thymosin Alpha-1 10 mg provides synergistic immune modulation. For those seeking cellular rejuvenation and DNA repair support, Epitalon 50 mg offers complementary benefits. For comprehensive tissue regeneration and health optimization, combining with TB-500 5 mg can enhance overall cellular health. For users focused on mitochondrial function and energy optimization, SS-31 50 mg pairs well with PNC-27's cellular targeting properties.
Health & Ancillary Support:
While PNC-27 does not affect hormonal pathways directly, maintaining overall health is essential for optimal research outcomes. For athletes using anabolic steroids, comprehensive cardiovascular and health support is recommended—consider incorporating Atorvastatin 40 mg for lipid management. Additionally, proper hydration, adequate sleep, and a nutrient-dense diet rich in antioxidants are crucial to supporting the body's natural cellular health mechanisms during research protocols.
Storage Instructions
Proper storage is essential to maintain the integrity and potency of PNC-27.
- Lyophilized Powder: Store in a cool, dry place away from direct light at room temperature (up to 25°C / 77°F).
- Post-Reconstitution: Once mixed with bacteriostatic water, the solution must be refrigerated at 2-8°C (36-46°F).
- Stability: Use the reconstituted solution within 28-30 days to ensure optimal peptide efficacy.
- Important: Do not freeze the reconstituted solution, as this can degrade the peptide structure.
Frequently Asked Questions
What is PNC-27 and how does it work?
PNC-27 is a 32-amino-acid synthetic peptide that targets membrane-bound HDM-2 proteins overexpressed on tumor cells. It binds to these proteins and induces cell membrane disruption, leading to rapid cell lysis and necrosis. Importantly, it spares healthy cells that do not express HDM-2 on their surface, making it highly selective.
How do I reconstitute PNC-27 10 mg?
To reconstitute PNC-27, add 2 mL of bacteriostatic water to the vial. Gently swirl until the powder is fully dissolved. Avoid shaking vigorously. This yields a concentration of 5 mg/mL for accurate dosing. Always use sterile techniques and equipment.
What are the recommended dosages for PNC-27?
Based on preclinical research and user experience, common dosages range from 100-300 mcg per day. Beginners should start at 100 mcg daily for 4 weeks, while more advanced users may work up to 300 mcg per day for 8 weeks. Always start with the lowest effective dose and monitor your response carefully.
Can PNC-27 be stacked with other peptides?
Yes, PNC-27 can be stacked with other peptides for comprehensive research protocols. Common combinations include Thymosin Alpha-1 for immune support, Epitalon for cellular rejuvenation, TB-500 for tissue regeneration, and SS-31 for mitochondrial health. Always research compatibility and use appropriate cycling protocols.
What is the significance of HDM-2 targeting in PNC-27?
HDM-2 is an oncogene that is overexpressed in many cancer cell types. It functions as a negative regulator of the tumor suppressor protein p53. By targeting HDM-2 on the cell membrane, PNC-27 specifically recognizes and binds to cells that overexpress this protein. This targeting mechanism is what gives PNC-27 its remarkable selectivity, allowing it to induce cell lysis in targeted cells while sparing healthy tissues that do not express HDM-2 on their surface.
